Dr. Shobi Sivathamboo is internationally recognised for her work on sudden unexpected death in epilepsy (SUDEP). She leads the SUDEP research group at Monash University, which has a focus on uncovering the incidence and biomarkers for SUDEP risk, as well as developing novel technologies for out-of-hospital seizure detection, timely alerts, and early detection of high-risk individuals.

She completed her PhD at the University of Melbourne in 2019 on cardiorespiratory function in epilepsy, which discovered that ~10% of patients with chronic drug-resistant epilepsy had serious cardiac abnormalities identified through long-term subcutaneous monitoring, that went undetected from routine epilepsy and cardiac investigations.

She has obtained funding totalling >$2.5M from competitive and industry funding bodies, and currently holds an NHMRC Emerging Leadership Grant. She has published in several leading peer-reviewed journals and been an invited speaker at various national and international forums, including the International Epilepsy Congress, Epilepsy Society of Australia, and the Canadian League Against Epilepsy. She is a member of the International League Against Epilepsy (ILAE) SUDEP Task Force. She is a principal investigator for the largest global efforts to study SUDEP risk factors and biomarkers across 86 epilepsy centres.